Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord

171Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An anticoagulant fraction was isolated from the homogenate of human umbilical cord arteries, using Sephadex gel filtration and DEAE‐Sephacel chromatography. Analysis with dodecyl sulfate/polyacrylamide gel electrophoresis and inactivation studies using proteolytic enzymes indicate that the anticoagulant activity is associated with a polypeptide with an apparent Mr of 32000. The anticoagulant inhibits thromboplastin as well as factor Xa induced clotting but does not affect thrombin initiated fibrin formation. The anticoagulant inhibits the activation of prothrombin by the complete prothrombinase complex, by phospholipid bound factor Xa but not by free factor Xa. The inhibition is instantaneous and independent of the incubation time over the whole range of concentrations tested. Therefore, the anticoagulant is unlikely to be a phospholipase or a protease. Its action does not resemble that of the plasma protease inhibitors, but it probably interferes with the phospholipid–clotting factor interactions. Copyright © 1985, Wiley Blackwell. All rights reserved

Cite

CITATION STYLE

APA

REUTELINGSPERGER, C. P. M., HORNSTRA, G., & HEMKER, H. C. (1985). Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. European Journal of Biochemistry, 151(3), 625–629. https://doi.org/10.1111/j.1432-1033.1985.tb09150.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free